Alto Neuroscience Pipeline
| Drug | Indication | Phase |
|---|
| ALTO-100 | Major Depressive Disorder (MDD) | Phase 2a |
| ALTO-101 | Cognitive Impairment Associated with Schizophrenia (CIAS) | Phase 2b |
| ALTO-202 | Anhedonic Depression (MDD) | Phase 2a |
| ALTO-300 | Major Depressive Disorder (MDD) | Phase 2a |
| ALTO-203 | MDD, Bipolar Depression | Phase 1 |